Sex-based differences in chronic total occlusion management and long-term clinical outcomes. (15th November 2020)

• Record Type: Journal Article
• Authors: Flores-Umanzor, Eduardo Josué; Cepas-Guillen, Pedro L.; Caldentey, Guillem; Pérez-Fuentes, Pedro; Arévalos, Victor; Ivey-Miranda, Juan; Regueiro, Ander; Freixa, Xavier; Brugaletta, Salvatore; Farrero, Marta; Andrea, Rut; Roquè, Mercé; Ferreira-González, Ignacio; Martin-Yusté, Victoria; Sabaté, Manel
• Is Part Of: International journal of cardiology. Volume 319(2020)
• Page Start: 46
• Page End: 51
• Publication Date: 2020-11-15
• Subjects: chronic total occlusion -- ex -- linical outcomes -- evascularization; ACEF age, creatinine, ejection fraction -- CABG coronary artery bypass graft -- CAD coronary artery disease -- CI confidence interval -- CTO chronic total occlusion -- DM diabetes mellitus -- HR hazard ratio -- MT medical treatment -- PCI percutaneous coronary intervention -- TIMI thrombolysis in myocardial infarction; Cardiology -- Periodicals; Electronic journals; 616.12
• DOI: 10.1016/j.ijcard.2020.05.090
• Languages: English
• ISSNs: 0167-5273

Abstract

Abstract: Background: Sex differences in coronary artery disease presentation and outcomes have been described. The aim of this study was to compare sex disparities in chronic total occlusion (CTO) management and long-term outcomes. Methods: All consecutive patients with at least one CTO diagnosed in our center between 2010 and 2014 were included. Demographic and clinical data were registered. All-cause and cardiac mortality were assessed during a median follow-up of 4.03 years (IQR 2.6–4.8). Results: A total of 1248 patients (67.3 ± 10.9 years; 16% female) were identified. Women were older, had a higher prevalence of type 2 DM and a lower ventricle ejection fraction compared to men ( p < .05). Although women had major proportion of positive result for severe ischemia-viability test (86% vs. 74%; p = .01), they were more often treated with MT alone compared to male (57% vs 51%; p = .02). During follow-up, 386 patients (31%) died. Women presented a higher rate of all-cause and cardiac mortality, and hospitalizations for heart failure independently of treatment strategy, compared to men ( p < .001). In multivariable analysis female sex was associated with higher cardiac mortality [HR 1.67, 95% CI 1.10–2.57; p < .001]. Among women, the independent predictors for all-cause and cardiac mortalities were age, MT of the CTO and ACEF (age, creatinin and ejection fraction) score. Conclusions: A significant sex gap regarding CTO treatment was observed. Female sex was an independent predictor for cardiac mortality at long-term follow-up. More data are needed to support these findings. Highlights: Despite recent advancements in CTO treatments, a significant sex gap remains. Women were more often treated with MT alone, but men were more likely to undergo invasive strategies. Female sex in CTO patients was associated with higher cardiac mortality.